NasdaqCM - Delayed Quote USD

Notable Labs, Ltd. (NTBL)

0.8550 -0.0500 (-5.52%)
At close: June 7 at 4:00 PM EDT
0.8859 +0.03 (+3.61%)
After hours: June 7 at 6:25 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
311.0000
310.0000
8.0000
285.0000
Cost of Revenue
197.0000
197.0000
--
--
Gross Profit
114.0000
113.0000
8.0000
285.0000
Operating Expense
13,090.0000
14,770.0000
12,932.0000
17,199.0000
Operating Income
-12,976.0000
-14,657.0000
-12,924.0000
-16,914.0000
Other Income Expense
4,218.0000
3,393.0000
-1,483.0000
862.0000
Pretax Income
-8,758.0000
-11,264.0000
-14,407.0000
-16,052.0000
Net Income Common Stockholders
-8,758.0000
-11,264.0000
-14,407.0000
-16,052.0000
Diluted NI Available to Com Stockholders
-8,758.0000
-11,264.0000
-14,407.0000
-16,052.0000
Basic EPS
-0.97
-3.41
-1.61
-1.80
Diluted EPS
-0.97
-3.41
-1.61
-1.80
Basic Average Shares
9,018.2610
3,302.8180
8,936.4480
8,936.4480
Diluted Average Shares
9,018.2610
3,302.8180
8,936.4480
8,936.4480
Total Operating Income as Reported
-12,976.0000
-14,657.0000
-12,924.0000
-16,914.0000
Total Expenses
13,287.0000
14,967.0000
12,932.0000
17,199.0000
Net Income from Continuing & Discontinued Operation
-8,758.0000
-11,264.0000
-14,407.0000
-16,052.0000
Normalized Income
-12,623.0000
-16,214.0000
-11,892.0000
-16,052.0000
EBIT
-12,976.0000
-14,657.0000
-12,924.0000
-16,914.0000
EBITDA
-12,724.0000
-14,400.0000
-12,601.0000
-16,588.0000
Reconciled Cost of Revenue
197.0000
197.0000
--
--
Reconciled Depreciation
252.0000
257.0000
323.0000
326.0000
Net Income from Continuing Operation Net Minority Interest
-8,758.0000
-11,264.0000
-14,407.0000
-16,052.0000
Total Unusual Items Excluding Goodwill
3,865.0000
4,950.0000
-2,515.0000
--
Total Unusual Items
3,865.0000
4,950.0000
-2,515.0000
--
Normalized EBITDA
-16,589.0000
-19,350.0000
-10,086.0000
-16,588.0000
12/31/2021 - 10/1/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AEON AEON Biopharma, Inc.
1.6800
+2.44%
 
CHRO Chromocell Therapeutics Corporation
1.4200
-4.05%
 
NLSP NLS Pharmaceutics AG
0.1277
-5.69%
 
QLGN Qualigen Therapeutics, Inc.
0.2000
-9.09%
 
GRI GRI Bio, Inc.
0.2784
-4.00%
 
INM InMed Pharmaceuticals Inc.
0.2354
-7.69%
 
ELDN Eledon Pharmaceuticals, Inc.
2.7800
+2.21%
 
RVU.WA Ryvu Therapeutics S.A.
53.30
-1.30%
 
CKDXF Opthea Limited
0.2900
-30.95%
 
BSLNz.XC